Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $87.02 USD
Change Today -0.43 / -0.49%
Volume 13.1M
As of 8:04 PM 11/25/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - valeant pharmaceuticals inte (VRX)

NameBoard RelationshipsTitleAge
J. Michael Pearson 33 RelationshipsChairman and Chief Executive Officer56
Robert L. Rosiello 2 RelationshipsChief Financial Officer and Executive Vice President--
Pavel Mirovsky No RelationshipsPresident of Valeant Europe and General Manager of Valeant Europe64
Robert Roswell Chai-Onn 14 RelationshipsChief Legal Officer, Executive Vice President, Head of Corporate & Business Development and General Counsel45
Deborah A. Jorn No RelationshipsExecutive Vice President, and Company Group Chairman--

Board Members - valeant pharmaceuticals inte (VRX)

NameBoard RelationshipsPrimary CompanyAge
J. Michael Pearson 33 RelationshipsValeant Pharmaceuticals International, Inc.56
Robert N. Power 20 RelationshipsValeant Pharmaceuticals International, Inc.58
H. Christian Fibiger Ph.D.31 RelationshipsMedGenesis Therapeutix Inc.72
Norma Ann Provencio 45 RelationshipsValeant Pharmaceuticals International, Inc.58
Ronald Harold Farmer 69 RelationshipsBank of Montreal65

Executive Committees* - valeant pharmaceuticals inte (VRX)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeNorma Ann Provencio 45 Relationships3 Executives
Compensation CommitteeRonald Harold Farmer 69 Relationships4 Executives
Nominating CommitteeRobert N. Power 20 Relationships4 Executives
Corporate Governance CommitteeRobert N. Power 20 Relationships4 Executives
Advisory BoardH. Christian Fibiger Ph.D. 31 Relationships6 Executives
View VRX Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRX:US $87.02 USD -0.43

VRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Astellas Pharma Inc ¥1,744 JPY -12.00
Eisai Co Ltd ¥8,195 JPY +1.00
Endo International PLC $61.00 USD +0.72
Mylan NV $51.80 USD +1.41
Sun Pharmaceutical Industries Ltd 737.40 INR +1.50
View Industry Companies

Industry Analysis


Industry Average

Valuation VRX Industry Range
Price/Earnings 49.6x
Price/Sales 3.0x
Price/Book 4.7x
Price/Cash Flow 11.6x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact VALEANT PHARMACEUTICALS INTE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at